Reckitt Benckiser Group’s (RKT) “Hold” Rating Reiterated at Jefferies Financial Group

Reckitt Benckiser Group (LON:RKT)‘s stock had its “hold” rating reaffirmed by stock analysts at Jefferies Financial Group in a report issued on Monday, LSE.Co.UK reports. They presently have a GBX 4,400 ($56.91) price objective on the stock. Jefferies Financial Group’s target price indicates a potential upside of 7.03% from the stock’s current price.

RKT has been the subject of several other research reports. HSBC reiterated a “hold” rating on shares of Reckitt Benckiser Group in a report on Thursday, April 18th. Berenberg Bank upped their price target on shares of Reckitt Benckiser Group from GBX 5,100 ($65.96) to GBX 5,200 ($67.25) and gave the company a “hold” rating in a report on Wednesday, July 24th.

Reckitt Benckiser Group Trading Down 8.4 %

LON RKT traded down GBX 375 ($4.85) during trading on Monday, reaching GBX 4,111 ($53.17). 267,491,219 shares of the stock traded hands, compared to its average volume of 4,020,805. The firm has a market cap of £28.95 billion, a price-to-earnings ratio of 1,794.71, a price-to-earnings-growth ratio of 1.64 and a beta of 0.06. The stock’s 50-day moving average price is GBX 4,390.83 and its 200 day moving average price is GBX 4,767.05. The company has a quick ratio of 0.46, a current ratio of 0.64 and a debt-to-equity ratio of 100.80. Reckitt Benckiser Group has a fifty-two week low of GBX 4,034 ($52.17) and a fifty-two week high of GBX 6,006 ($77.68).

Insider Transactions at Reckitt Benckiser Group

In other Reckitt Benckiser Group news, insider Tamara Ingram acquired 350 shares of the business’s stock in a transaction dated Wednesday, June 5th. The shares were acquired at an average price of GBX 4,509 ($58.32) per share, with a total value of £15,781.50 ($20,410.63). In other news, insider Tamara Ingram purchased 350 shares of the company’s stock in a transaction on Wednesday, June 5th. The shares were purchased at an average cost of GBX 4,509 ($58.32) per share, with a total value of £15,781.50 ($20,410.63). Also, insider Kris Licht sold 10,344 shares of the company’s stock in a transaction on Thursday, May 2nd. The stock was sold at an average price of GBX 4,479 ($57.93), for a total transaction of £463,307.76 ($599,208.17). 0.07% of the stock is currently owned by insiders.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.